In one paragraphArticle in mBio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Adam W E Stewart *School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia.ORCID 0000-0002-2087-3760 Jinling Li *School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia.
Mihwa LeeSchool of Chemistry and Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia.
Jessica M LewisDepartment of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
Marion HerisseDepartment of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
Vinzenz HofferekDepartment of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne,, Parkville, Victoria, Australia.
Malcolm J McConvilleDepartment of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne,, Parkville, Victoria, Australia.ORCID 0000-0002-7107-7887 Sacha J PidotDepartment of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.ORCID 0000-0003-1202-6614 Nichollas E ScottDepartment of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.ORCID 0000-0003-2556-8316 Spencer J WilliamsSchool of Chemistry and Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia.ORCID 0000-0001-6341-4364 Funding
Department of Education and Training DP210100233, DP210100235, DP240100126, DP250100819Department of Education and Training DP230102668Department of Education and Training FT200100270, DP210100362National Health and Medical Research Council GNT2021638
6 · The paper itselfAbstract
The rare sulfosugar sulfofucose (6-deoxy-6-sulfo-D-galactose) is catabolized by
Indexed as
Metabolic Networks and PathwaysBacterial ProteinsMetabolomicsProteomicsSoil MicrobiologySulfitesBacterial ProteinsSulfitescatabolismmetabolismorganosulfursulfoglycolysissulfur cycle
Identifiers
PMID40823846
PMCPMC12421959
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390